July 12, 2021 – Recently, local golf enthusiasts gathered at Madison Green Country Club to tee off for a worthy cause: fighting Alzheimer’s disease. Hosted by Golf Fore A Cure, the charity golf outing raised $5,000 in support of the care, support and research programs of the Alzheimer’s Association.
 
“Golf Fore A Cure is a nonprofit organization dedicated to raising funds for Alzheimer’s research,” said David Schue, event organizer and founder of Golf Fore a Cure. “We plan golf outings as a context for having fun and also to raise money for this worthy cause.”
 
Funds raised through the June 20 event – which coincided with the longest day of the year, the summer solstice – benefited The Longest Day, an annual Alzheimer’s Association fundraising initiative that encourages participants to combat the darkness of Alzheimer’s disease through the activity of their choice.
According to the Alzheimer’s Association, more than 6 million Americans are living with Alzheimer’s, including 580,000 Floridians. Florida is also home to more than 527,000 family caregivers who provide daily care to loved ones with dementia.
 
“In Palm Beach County alone, there are estimated to be more than 51,000 individuals with Alzheimer’s disease,” noted Haley Register, The Longest Day manager for the Alzheimer’s Association Southeast Florida Chapter. “For so many of their neighbors and friends to come out and show their support is truly touching, and with their help, we hope to finally put an end to not only Alzheimer’s but all forms of dementia.” 
 
For more information about The Longest Day, visit www.alz.org/thelongestday. 
 
Alzheimer’s Association
The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s. For more information, visit www.alz.org or call 800.272.3900.
 


July 12, 2021 – Haroula Protopapadakis Norden has been appointed Chief Operating Officer of Boca Raton Regional Hospital, part of Baptist Health South Florida.

Effective today, Ms. Protopapadakis Norden assumes her new role. She will help oversee daily operations and play a critical role in the hospital’s expansion and renovation, upholding Boca Regional’s outstanding clinical care and patient satisfaction.
 
“We are very pleased to welcome Haroula Protopapadakis Norden. She brings with her a record of proven leadership and a passion for excellence and innovation,” says Lincoln Mendez, CEO of Boca Raton Regional Hospital. “We know she will be a valued member of our team.”
 
Ms. Protopapadakis Norden is a Fellow of the American College of Healthcare Executives and served as the 2020 President of the South Florida chapter’s board of directors. She comes to Boca Regional Hospital from Memorial Regional Hospital in Hollywood, where she worked for more than 15 years and most recently served as Associate Administrator.
 
At Memorial, she led the construction of the hospital’s $43 million parking garage and conference center, in addition to overseeing the Neuroscience Institute for the system and the hospital’s departments of trauma medicine, imaging, inpatient rehabilitation, environmental services, food and nutrition and more.
 
Born and raised in South Florida, Ms. Protopapadakis Norden earned her Master of Business Administration degree with a certificate in hospital administration from Nova Southeastern University in Davie. She also earned her Bachelor of Science at NSU.
 
Ms. Protopapadakis Norden is active in a number of community causes. In 2020, she was a March of Dimes Women of Distinction honoree. She also has participated in Leadership Broward and in mentoring programs at both Florida Atlantic University and Florida International University, with an emphasis on healthcare.
 
“I’m very happy to join the team at Boca Raton Regional Hospital, which has such a stellar reputation,” Ms. Protopapadakis Norden says. “The hospital is growing significantly, and in doing so is exploring new ways to serve the community, its patients and their families. It’s an exciting time to be here and I look
 
forward to all we will accomplish.”
 
About Boca Raton Regional Hospital
Boca Raton Regional Hospital is part of Baptist Health South Florida, the largest healthcare organization in the region, with 11 hospitals, nearly 23,000 employees, more than 4,000 physicians and more than 100 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and Baptist Health Care On Demand, a virtual health platform. Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.
 
Boca Raton Regional Hospital is supported by philanthropy to strengthen its mission to deliver the highest quality patient care, satisfaction and safety. If you would like to learn more about supporting the mission of Boca Raton Regional Hospital, visit our website at donate.brrh.com.
 
For more information, visit BRRH.com and connect with us on Facebook, Instagram, Twitter and  LinkedIn.
 
 


July 12 2021 – West Boca Medical Center recently unveiled its new Boca Center for Women’s Care. The center has a new name, but is still delivering the same quality care expectant moms can count on when getting ready to deliver their new bundle of joy. The hospital also has a new laborist program, which offers in-house physicians, who are specialized obstetricians and gynecologists.  
 
 
They are available 24/7 to care for all maternity, labor and delivery needs.  The hospital also has aromatherapy, a celebration breakfast, postpartum snack pack and a Level III Neonatal Intensive Care Unit.  
 
For more information about the services at the Boca Center for Women’s Care, visit www.WestBocaMedCtr.com/Baby.


July 11 2021 – Dr. Jeff Gelblum, MD, a board-certified neurologist with First Choice Neurology, the nation’s largest neurology practice, is scheduled to treat the first patient in Florida with Biogen’s Aducanumab, a monthly infusion treatment for early stage Alzheimer’s patients. The drug works to decrease amyloid plaque in the brain, which is a marker for Alzheimer’s disease.
 
According to Dr. Gelblum, Florida’s first Aducanumab patient is a middle-aged woman who is in good health and lives in Aventura.  Showing signs of mild Alzheimer’s, she underwent a series of tests at First Choice Neurology offices to determine her qualification for the treatment.
 
“Not every Alzheimer’s patient is eligible to receive this treatment,” said Dr. Gelblum. “A patient must undergo a thorough evaluation before infusions are started.”
 
To derive maximum benefit from this new drug, Dr. Gelblum is selecting patients who are similar to the best responders in the Aduhelm clinical trials  — mild disease, confirmed amyloid plaque in the brain, and overall good health and functionality.
 
This evaluation, he explained, includes a brain MRI to confirm that the cognitive decline is not related to other causes, such as  stroke or hydrocephalus; a PET Scan or spinal tap to confirm that the plaque-forming amyloid protein is in fact present; and clinical assessments of independent activities of daily living, mood, and various cognitive tasks involving memory and attention. 
 
The Aduhelm treatment consists of a monthly IV dose of medication provided in a First Choice Neurology infusion center.  Doses gradually increase over a seven-month period and level off at 10mg/kg of weight. 
 
“We are extremely honored to be the first in Florida to bring this promising treatment to our patients,” added Dr. Gelblum. “For the past 18 years, we have been wandering in a treatment desert. Now, we have the chance to offer hope to our patients across the state.”
 
First Choice Neurology physicians are located in more than 40 locations, including Miami-Dade, Broward and Palm Beach Counties, as well as the Tampa Bay area in Central Florida.
 
 
About First Choice Neurology:
As the largest private pediatric and adult neurology group in the United States, First Choice 
 
Neurology has more than 80 neurologists and 120 support health care staff members, operating out of 41 facilities in six Florida counties and in 35 major hospitals.
 
The Florida medical group of neurologists, nurse practitioners, physician assistants, neuropsychologists as well as occupational therapists (OTs) and physical therapists (PTs), began serving patients in 2004 in response to South Florida’s increasing need for high-quality neurology services. First Choice offers both diagnostic and physical rehabilitative services for patients with a wide variety of neurological conditions, including Alzheimer’s disease, dementia, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, sleep disorders and strokes. Additional subspecialties include neuromuscular disorders, neuro-ophthalmology, pain management, neuropsychology, neuroradiology, physical medicine and rehabilitation.  
 
First Choice pediatric neurologists treat a wide range of conditions as well, including autism, cerebral palsy, medically resistant epilepsies, inflammatory and infectious diseases of the central nervous system, and neuro-developmental, genetic, and metabolic disorders.
 
For more information about First Choice Neurology, visit www.FCNeurology.net
 


July 9, 2021 – Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), today announced that effective at 5:00 pm, Eastern Time, on July 16, 2021 (the “Effective Time”), the Company will effect a 1 for 1,000 reverse stock split of its outstanding common stock. The Company’s common stock will open for trading on Monday July 19, 2021, on a post-split basis.
 
As a result of the reverse stock split, every 1,000 shares of the Company’s common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share, except to the extent that the reverse stock split results in any of the Company’s stockholders owning a fractional share, which fractional share will be in that case paid in cash. In connection with the reverse stock split, there will be no change in the nominal par value per share of $0.0001.
 
Trading of the Company’s common stock will continue, on a split-adjusted basis, with the opening of the markets on Monday, July 19, 2021. Based on the number of shares currently outstanding, on July 9, 2021, the reverse stock split will reduce the number of shares of the Company’s common stock outstanding from approximately 10 billion pre-reverse split shares to approximately 10 million post-reverse split.
 
All outstanding preferred shares, stock options, warrants, and equity incentive plans immediately prior to the reverse stock split generally will be appropriately adjusted by dividing the number of shares of common stock into which the preferred shares, stock options, warrants and equity incentive plans are exercisable or convertible by 1,000 and multiplying the exercise or conversion price by 1,000, as a result of the reverse stock split.
 
The Company has retained its transfer agent, Computershare, Inc., to act as its exchange agent for the reverse stock split. Computershare will provide stockholders of record as of the Effective Time a letter of transmittal providing instructions for the exchange of their stock certificates. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers’ particular processes, and will not be required to take any action in connection with the reverse stock split.
 
The reverse stock split was approved by the directors of the Company on July 8, 2021, pursuant to a resolution adopted by written consent of the holders of the majority of the total voting power of the Company’s securities on June 15, 2021
About Rennova Health, Inc. 
Rennova owns rural hospitals and a physician’s office in Tennessee and a physician’s office in Kentucky. For more information, please visit www.rennovahealth.com